Resonance Health Limited (ASX:RHT)

Resonance Health Statistics

Total Valuation

ASX:RHT has a market cap or net worth of AUD 20.89 million. The enterprise value is 21.72 million.

Market Cap	20.89M
Enterprise Value	21.72M

Important Dates

The next estimated earnings date is Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

ASX:RHT has 474.79 million shares outstanding. The number of shares has decreased by -2.81% in one year.

Current Share Class	474.79M
Shares Outstanding	474.79M
Shares Change (YoY)	-2.81%
Shares Change (QoQ)	+2.13%
Owned by Insiders (%)	38.18%
Owned by Institutions (%)	0.73%
Float	274.02M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.89
PB Ratio	2.22
P/TBV Ratio	8.70
P/FCF Ratio	25.94
P/OCF Ratio	16.73
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-12.53
EV / Sales	1.96
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	26.96

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.40.

Current Ratio	1.28
Quick Ratio	1.25
Debt / Equity	0.40
Debt / EBITDA	n/a
Debt / FCF	4.72
Interest Coverage	-4.97

Financial Efficiency

Return on equity (ROE) is -17.05% and return on invested capital (ROIC) is -7.11%.

Return on Equity (ROE)	-17.05%
Return on Assets (ROA)	-5.19%
Return on Invested Capital (ROIC)	-7.11%
Return on Capital Employed (ROCE)	-12.46%
Revenue Per Employee	692,064
Profits Per Employee	-108,309
Employee Count	16
Asset Turnover	0.58
Inventory Turnover	n/a

Taxes

Income Tax	-465,933
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.98% in the last 52 weeks. The beta is 1.21, so ASX:RHT's price volatility has been higher than the market average.

Beta (5Y)	1.21
52-Week Price Change	-16.98%
50-Day Moving Average	0.05
200-Day Moving Average	0.04
Relative Strength Index (RSI)	46.97
Average Volume (20 Days)	245,539

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:RHT had revenue of AUD 11.07 million and -1.73 million in losses. Loss per share was -0.00.

Revenue	11.07M
Gross Profit	11.07M
Operating Income	-1.58M
Pretax Income	-2.20M
Net Income	-1.73M
EBITDA	-1.41M
EBIT	-1.58M
Loss Per Share	-0.00

Balance Sheet

The company has 2.98 million in cash and 3.80 million in debt, with a net cash position of -826,091 or -0.00 per share.

Cash & Cash Equivalents	2.98M
Total Debt	3.80M
Net Cash	-826,091
Net Cash Per Share	-0.00
Equity (Book Value)	9.39M
Book Value Per Share	0.02
Working Capital	1.43M

Cash Flow

In the last 12 months, operating cash flow was 1.25 million and capital expenditures -443,124, giving a free cash flow of 805,391.

Operating Cash Flow	1.25M
Capital Expenditures	-443,124
Free Cash Flow	805,391
FCF Per Share	0.00

Margins

Gross margin is 100.00%, with operating and profit margins of -14.30% and -15.65%.

Gross Margin	100.00%
Operating Margin	-14.30%
Pretax Margin	-19.86%
Profit Margin	-15.65%
EBITDA Margin	-12.72%
EBIT Margin	-14.30%
FCF Margin	7.27%

Dividends & Yields

ASX:RHT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.81%
Shareholder Yield	2.81%
Earnings Yield	-8.30%
FCF Yield	3.86%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 15, 2003. It was a reverse split with a ratio of 0.1.

Last Split Date	Oct 15, 2003
Split Type	Reverse
Split Ratio	0.1

Scores

ASX:RHT has an Altman Z-Score of -3.23 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.23
Piotroski F-Score	3